BDBM50177611 2-(5-(2,3-difluorobenzylthio)-2-aminothiazolo[4,5-d]pyrimidin-7-ylamino)-2-methylpropan-1-ol::CHEMBL380947
SMILES: CC(C)(CO)Nc1nc(SCc2cccc(F)c2F)nc2nc(N)sc12
InChI Key: InChIKey=UTDWJMBRBOKFJV-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-X-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50177611 (2-(5-(2,3-difluorobenzylthio)-2-aminothiazolo[4,5-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Charnwood Curated by ChEMBL | Assay Description Displacement of [125I]IL8 from human recombinant CXCR2 expressed in HEK293 membranes by SPA | Bioorg Med Chem Lett 16: 960-3 (2006) Article DOI: 10.1016/j.bmcl.2005.10.091 BindingDB Entry DOI: 10.7270/Q2D79B09 | |||||||||||
More data for this Ligand-Target Pair |